SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sequent Scientific - Quaterly Results

25 May 2022 Evaluate
The sales declined to Rs. 636.73 millions for the March 2022 quarter as compared to Rs. 694.79 millions during the corresponding quarter last year.Good  Net Profit growth of 43.18% reported above the corresponding previous quarter figure of Rs. 46.43 millions to Rs. 66.48 millioins.OP of the company witnessed a marginal growth to 109.86 millions from 88.00 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 636.73 694.79 -8.36 2196.26 2654.57 -17.26 2196.26 2654.57 -17.26
Other Income 57.72 59.21 -2.52 276.43 199.66 38.45 276.43 199.66 38.45
PBIDT 109.86 88.00 24.84 268.93 552.56 -51.33 268.93 552.56 -51.33
Interest 6.08 2.50 143.20 16.10 26.80 -39.93 16.10 26.80 -39.93
PBDT 103.78 86.37 20.16 252.83 500.15 -49.45 252.83 500.15 -49.45
Depreciation 23.41 26.07 -10.20 95.93 91.28 5.09 95.93 91.28 5.09
PBT 80.37 60.30 33.28 156.90 408.87 -61.63 156.90 408.87 -61.63
TAX 13.89 13.87 0.14 8.91 87.74 -89.84 8.91 87.74 -89.84
Deferred Tax 3.04 5.67 -46.38 5.20 26.89 -80.66 5.20 26.89 -80.66
PAT 66.48 46.43 43.18 147.99 321.13 -53.92 147.99 321.13 -53.92
Equity 496.74 496.74 0.00 496.74 496.74 0.00 496.74 496.74 0.00
PBIDTM(%) 17.25 12.67 36.22 12.24 20.82 -41.17 12.24 20.82 -41.17

Viyash Scientific Share Price

208.90 0.05 (0.02%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×